Classifications

• • C—CHEMISTRY; METALLURGY
  • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
  • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
  • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
  • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
  • C12Q1/6813—Hybridisation assays
  • C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism

Definitions

• the present invention relates to a method for distinguishing 5-position methylation changes from cytosine bases and cytosm-to-thymine mutations and for detecting single nucleotide polymorphisms (SNPs) or point mutations in genomic DNA
• the present invention describes a method for
• Detection of the methylation state of genomic DNA samples in particular mutations and cytosine methylations can be distinguished from one another.
• the method can also be used to find point mutations and single nucleotide polymorphisms (SNPs).
• 5-Methylcytosm is the most common covalently modified base in the DNA of eukaryotic cells. For example, it plays a role in the regulation of transcept
• the first principal method is based on the use of residual endonucleases (RE), which are “sensitive to methylation”.
• REs are distinguished by the fact that they cut a DNA into a specific DNA sequence, usually between 4 and 8 bases long The position of such cuts can then be verified by gel electrophoresis, transfer to a membrane and hybridization. Methylation-sensitive means that certain bases within the recognition sequence must be unmethylated in order for the cut to take place. The band pattern after a restriction cut and gel electrophoresis therefore changes according to the methylation pattern of DNA.
• the fewest methylable CpG are found within the recognition sequences of REs, cannot be examined using this method.
• a variant combines PCR with this method, an amplification by two primers located on both sides of the recognition sequence takes place after a cut only if the recognition sequence is methylated.
• the sensitivity increases theoretically to a single molecule of the target sequence, but only individual positions can be examined with great effort (Shemer, R. et al., PNAS 93, 6371-6376). Again, it is a prerequisite that the methylable position is within the recognition sequence of a RE.
• the second variant is based on partial chemical cleavage of total DNA, following the example of a Maxam-Gilbert sequencing reaction, ligation of adapters to the ends generated in this way, amplification with generic numbers and separation on gel electrophoresis. With this method, defined areas up to the size of less than a thousand base pairs can be examined. However, the process is so complicated and unreliable that it is practically no longer used (Ward, C. et al., J. Biol. Chem. 265, 3030-3033).
• a relatively new and the most frequently used method for examining DNA for 5-methylcytosm is based on the specific reaction of bisulphite with cytosine, which is converted into uracil after subsequent alkaline hydrolysis, which corresponds to the thymidm in its base-pairing behavior.
• 5-methylcytosm is not modified under these conditions. This transforms the original DNA into methyl cytosm, which originally cannot be distinguished from cytosine by its hybridization behavior, can now be detected by "normal" molecular biological techniques as the only remaining cytosine, for example by amplification and hybridization or sequencing.
• the technique in terms of sensitivity is defined by a method that includes the DNA to be examined in an agarose matrix, thereby preventing the diffusion and renaturation of the DNA (bisulphite only reacts to single-stranded DNA) and all precipitation and purification steps by rapid Dialysis replaces (Olek, A. et al., Nucl. Acids. Res. 24, 5064-5066).
• This method can be used to examine individual cells, which illustrates the potential of the method.
• only individual regions up to approximately 3000 base pairs have so far been used Long studied, a global study of cells for Ta End of possible methylation events is not possible.
• this method too, cannot reliably analyze very small fragments from small sample quantities. Despite the diffusion protection, these are lost through the matrix.
• Matrix-assisted laser desorption / ionization mass spectrometry is a new, very powerful development for the analysis of biomolecules (Karas, M. and Hillenkamp, F. 1988. Laser desorption ionization of proteins with molecular masses exceedmg 10,000 daltons Anal Chem. 60: 2299-2301).
• An analyte molecule is embedded in a UV absorbing matrix. The matrix s vacuum is evaporated by a short laser pulse and the analyte is thus sent unfragmented into the gas phase.
• An applied voltage accelerates the ions into a field-free flight tube. Due to their different masses, ions are accelerated to different extents. Smaller ions reach the detector earlier than larger ones and the flight time is converted to the mass of the ions.
• Fluorescent-labeled probes have been used in many cases for scanning an immobilized DNA array.
• the simple attachment of Cy3 and Cy5 dyes to the 5 'OH of the respective probe is particularly suitable for fluorescence labeling.
• the fluorescence of the hybridized probes is detected, for example, using a confocal microscope.
• the dyes Cy3 and Cy5, among many others, are commercially available.
• Methylases that methylate cytos bases in certain sequence contexts are known and some are also commercially available.
• Sssl methylase for example, methylates cytosine in the context context CpG (see e.g. Renbaum, P. et al. (1990), Nucleic Acids Res. 18, 1145) and is e.g. B. Available from New England Biolabs, as well as other methylases such as Alul, BamHl or Haelll.
• methylated cytosine positions cannot be detected with certainty. If em thym instead of a cytosm is detected at the position in question, it may be a mutation compared to the reference sequence used, but it may also be em cytosine not methylated in the genomic sample DNA, which is first in uracil and when the amplification was finally converted into thymm in the sequence context.
• the object of the present invention is therefore to solve this problem.
• the object is achieved in that a method for differentiating 5-position methylation changes from cytosm bases and cytosm-to-thymm mutations and
• SNPs single nucleotide polymorphisms
• a genomic DNA sample is treated with sulfite or disulfite or another chemical in such a way that all are not methylated at the 5-position of the base Cytosm bases are changed in such a way that a base which is different in terms of base pairing results, while the cytosines methylated at the 5-position remain unchanged and b) an aliquot of the same genomic DNA sample before the chemical treatment according to a) with Sssl or another methyl transferase quantitatively methylated and c) the two DNA samples treated in this way are examined for the presence of cytosine by means of the same analytical method and d) the cytosine positions determined are compared with a reference DNA sequence.
• SNPs single nucleotide polymorphisms
• the present invention therefore achieves the object in that a methylated aliquot of the same sample has the same is treated and the sequence information obtained is compared with the sequence of a reference DNA, a distinction between mutations and cytosine methylation being possible.
• a method is preferred according to the invention, in which a comparison of the individual cytosm positions from the two differently treated samples with the reference sequence determines whether cytosine cannot be detected at a specific position and whether this is due to the fact that the cytosine is in the genomic DNA is unmethylated or is modified by a mutation or a polymorphism and is therefore not present in the genomic DNA.
• a method which is characterized in that the two DNA samples or parts of these DNA samples are amplified using a cyclic process, namely the polymerase chain reaction or a comparable process, before the base cytosine is detected, is also in accordance with the invention.
• those primers are used for the amplification of the genomic DNA samples which contain so-called consensus sequences or such sequences which are important for gene regulation and which thus bind predominantly to regulatory or coding sequences.
• cytosine is detected in the specific context 5'-CpG-3 '.
• the DNA is provided with one or more detectable labels as a whole by incorporating nucleotide building blocks or oligonucleotides provided with a detectable label.
• the detection of the label is carried out by fluorescence or chemiluminescence.
• cytosine is detected by hybridization with oligomers specific for "sequence context-cytosine sequence context", which are fixed in a defined arrangement on one or more surfaces.
• each cytosine to be detected in its sequence-specific context at least one oligomer which is complementary to the sequence context and which contains the guanine which is complementary to the cytosine to be detected and another oligomer which is to be found in the place of the cytosine to be detected is fixed on the surface.
• cytosine positions to be detected those oligomers are fixed which bind specifically to the methylated and unmethylated positions both on the plus and minus strand or / and specifically on the complementary strands which are formed as a result of amplification hybridize. It is further preferred that further oligomers are fixed on the surface, each of which specifically binds to the sequence "sequence context-thymine sequence context" and / or which cytosine and the base formed by chemical treatment in the plus strand, minus strand and the e Detect strands created by complementary strands.
• signals are detected from the oligomers at points on the surface (s) which are specific for the methylated, unmethylated or mutated in the original genomic sample.
• the absolute degree of methylation and / or the homo- or heterozygosity is determined by comparing the detected signals.
• the method is also in accordance with the invention, in which the amplified fragments of the two samples are fixed on a surface and hybridized with a detectable label, sequence-specific oligomers on these surfaces.
• the analysis of the hybridized sequence-specific oligomers is carried out by means of mass spectrometry and preferably a MALDI mass spectrometer.
• the analysis of the hybridized sequence-specific oligomers is carried out by means of fluorescence or chemiluminescence.
• a particularly preferred variant of the method according to the invention is that the detection of cytosine in the sequence context by a polymerase reaction, which is stopped when a cytosine base is reached in the template, and the resulting fragments are measured in length.
• the oligomers which are used to start the primer-dependent polymerase reaction are fixed in different sequences at different locations on a surface and that the polymerase reaction takes place on this surface.
• oligomers which are used to start the primer-dependent polymerase reaction are removed from the surface by a chemical reaction or by light.
• a nucleotide building block is used to terminate the polymerase reaction at the position of a cytosine or - in the opposite strand - of a guanine, which also allows detection by chemical modification, for example by fluorescence, chemiluminescence or the binding of an antibody.
• the termination is detected at the position of a cytosine or - in the opposite strand - a guanine by measuring the length of the resulting fragments by gel electrophoresis, in particular capillary electrophoresis.
• the length measurement of the resulting fragments is carried out by mass spectrometric analysis and preferably in a MALDI mass spectrometer.
• the method according to the invention is further characterized in that the reference DNA sequence comes from a database, namely from the human genome project.
• Another object of the present invention is a kit containing reference DNA and / or chemicals and auxiliaries for carrying out the bisulfite reaction and / or the amplification and / or a methyltransferase and / or documentation for carrying out the process according to the invention.
• Fig. 1 summarizes the method using the example of any sequence 1.
• a genomic DNA sample is treated chemically in such a way that all cytosine bases not methylated on the 5-position are changed in such a way that a base which is different in base pairing behavior is formed, while the cytosines methylated on the 5-position remain unchanged.
• a second step an aliquot of the same genomic DNA sample is placed before the chemical analysis described above. acted with Sssl or another methyltransferase.
• This methylation leads to the fact that all cytosm bases in the sequence context CG of the DNA sample or all other cytosm bases of the DNA sample with other methyl transferases are converted into 5-methylcytosm and thus no conversion into thymic can take place during the chemical treatment.
• both DNA samples are amplified according to the pretreatment steps described, again this is preferably carried out by means of PCR.
• a third step of the method the two treated DNA samples are examined for the presence of cytosine using the same analytical method.
• the determined cytosine positions are compared with those of a reference DNA sequence.
• this reference DNA sequence can be chosen arbitrarily, but cannot be identical to the sample examined.
• the reference sequence preferably comes from a database, such as is currently being created, for example, as part of the human genome project or is already available.
• the comparison with the reference DNA can now lead to the following results for a given position in the sample, depending on the detected cytosine bases: If cytosine is detected both in the methylated sample and in the unmethylated sample, this cytosine is present of the genomic DNA methylated before.
• the amplification in the second step is carried out in such a way that more than 10 different fragments are generated in an amplification batch. This can preferably be done by using primers which contain so-called consensus sequences or such sequences which are important for gene regulation and which thus predominantly bind to regulative or coding sequences.
• the products are preferably provided overall with one or more detectable labels by incorporation of nucleotide components or oligonucleotides (eg primers) provided with a detectable label, with the label being particularly preferably detected by fluorescence or chemiluminescence he follows.
• the cytosine positions are examined in such a way that cytosine is detected only in the specific context 5'-CpG-3 '.
• This can preferably be carried out by detecting the cytosine by hybridization with oligomers specific for "sequence context-cytosine sequence context", which are fixed in a defined arrangement on one or more surfaces.
• At least one oligomer which is complementary to the sequence context and which contains the guanine which is complementary to the cytosine to be detected and a further oligomer which is the base at the site of the cytosine to be detected is fixed on the surface contains which is complementary to the base into which unmethylated cytosines are converted by the chemical treatment.
• a bisulfite treatment is carried out, this is the base adenine which is complementary to the thyroid.
• those oligomers are fixed on the surface (s) which specifically bind to the methylated and unmethylated cytosine positions on both the plus and the minus strand or / and hybridize specifically to the complementary strands formed in each case by amplification.
• further 0-ligomers are fixed on the surface (s), each of which specifically binds to the sequence “sequence context-thymine sequence context” and / or which cytosine and the one produced by chemical treatment Detect the base in the plus strand, the minus strand and the strands created by complementary strands resulting from amplification.
• signals are detected at the points on the surface (s) at which the 0-ligomers are fixed, which are specific for those methylated in the original genomic sample, or unmethylated or mutated.
• the detected ones are in a preferred variant of the method
• Signals can be quantified so that the absolute degree of methylation and / or homo- or heterozygosity can be determined.
• the amplified fragments of the two samples, methylated and not methylated are each fixed to a surface and sequence-specific oligomers provided with a detectable label on these surfaces are hybridized to the two samples.
• the hybridized sequence-specific oligomers are analyzed by means of their fluorescence or chemiluminescence.
• the detection of cytosine in the sequence context is carried out by a polymerase reaction, which is specifically stopped when a cytosine base in the template is reached, and length measurement of the resulting fragments.
• the oligomers which are used to start the primer-dependent polymerase reaction can preferably each be fixed in different sequences at different locations on a surface and the polymerase reaction can preferably take place on this surface.
• the oligomers which are used to start the primer-dependent polymerase reaction can be detached from the surface by a chemical reaction or by light.
• a nucleotide building block is preferably used which, via chemical modification, also allows detection, for example by fluorescence, chemiluminescence or the binding of an antibody.
• the termination can also be detected at the position of a cytosine or - in the opposite strand - of a guanine by measuring the length of the resulting fragments by gel electrophoresis, in particular capillary electrophoresis.
• the length measurement of the resulting fragments is carried out by mass spectrometric analysis and preferably in a MALDI mass spectrometer.
• a kit can be used which contains reference DNA and / or chemicals and auxiliaries for carrying out the bisulfite reaction and / or the amplification and / or a methyltransferase and / or documentation for carrying out the method.
• point mutations from cytosine to thymine as thymine can be detected both in the bisulfite-treated and amplified and in the previously methylated, bisulfite-treated and amplified DNA.
• methylated cytosines are detected as cytosine
• unmethylated cytosines are only detected as T in the unmethylated sample and as C in the methylated sample.
• Section I from the genomic sequence entered in the database Genbank with the accession number AL031228 from position 117606 to position 118388.
• the underlying C / T identifies the C-SNP, which is located in the sequence with the accession number AL031228 at position 117606.
• Sequence B of the unmethylated and bisulfite-treated DNA is shown below.
• the C-SNP is at position 557, in the amplified fragment 2 with the length 783 (positions 303 to 1085) the C-SNP is at position 255
• the primers are in bold, for fragment 2 the primers are in bold and underlined.
• Genomic DNA is cut with the restriction enzyme Mssl (Fermentas) and then methylated with the enzyme Sssl (CpG Methylase, BioLabs).
• the bisulfite reaction is carried out in a manner known per se.
• the COL11A2 gene is amplified on chromosome 6p21.
• the amplification is carried out according to the general PCR protocol with the primer pair AAAAGGGTGGGGTTTTTAT, TCTCCTACCCCAAAAACTAA or with the primer pair TTTTTGGTTGGAGGATAAATA, AACCAACAAAACCCTACAAA. Both or only one primer of the respective primer pairs were labeled with Cy5.
• PCR approach (20 ⁇ L): l ⁇ L DNA (10 ng), each 2 ⁇ L (4x25mM) dNTPs, 0.2 ⁇ L (1 unit) Taq (Hot Star Taq®, Qiagen), 2 ⁇ L PCR buffer (lOx, Qiagen), each 1 ⁇ L Cy5 labeled primers (6.25 pmoL / ⁇ L) '
• Genomic DNA is cut with the restriction enzyme Mssl (Fermentas).
• the bisulfite reaction is carried out in accordance with the prior art listed.
• the COL11A2 gene is amplified on chromosome 6p21.
• the amplification is carried out according to the general PCR protocol with the primer pair AAAAGGGTGGGGTTTTTAT, TCTCCTACCCCAAAAACTAA or with the primer pair TTTTTGGTTGGAGGATAAATA, AACCAACAAAACCCTACAAA carried out. Both or only one primer of the respective primer pairs were labeled with Cy5.
• oligonucleotides which contain the sequences TTTAAGGGCGTGTGGTAT and TTTAAGGGTGTGGTAT, were fixed on a glass surface.
• glass supports are amplified with DNA fragment 1 from unmethylated bisulfite-treated DNA and amplified with DNA fragment 1 from methylated bisulfite-treated DNA and / or with DNA fragment 2 from unmethylated bisulfite-treated DNA and with DNA fragment 2 amplified from methylated bisulfite-treated DNA and hybridized in a manner known per se. This process is completely automated.
• Case 1 If methylated cytosine is present in the genomic sequence, cytosine is detected in the non-methylated bisulfite-treated DNA and in the methylated bisulfite-treated DNA.
• Case 3 If the genomic sequence has a point mutation (C-SNP), a thymm is detected in the unmethylated bisulfite-treated DNA and in the methylated bisulfite-treated DNA.
• C-SNP point mutation

Landscapes

• Chemical & Material Sciences (AREA)
• Organic Chemistry (AREA)
• Life Sciences & Earth Sciences (AREA)
• Zoology (AREA)
• Wood Science & Technology (AREA)
• Proteomics, Peptides & Aminoacids (AREA)
• Health & Medical Sciences (AREA)
• Engineering & Computer Science (AREA)
• Bioinformatics & Cheminformatics (AREA)
• Immunology (AREA)
• Microbiology (AREA)
• Molecular Biology (AREA)
• Biotechnology (AREA)
• Biophysics (AREA)
• Analytical Chemistry (AREA)
• Biochemistry (AREA)
• Physics & Mathematics (AREA)
• General Engineering & Computer Science (AREA)
• General Health & Medical Sciences (AREA)
• Genetics & Genomics (AREA)
• Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
• Mechanical Treatment Of Semiconductor (AREA)
• Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
• Investigating Or Analysing Biological Materials (AREA)
• Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
• Apparatus For Radiation Diagnosis (AREA)
• Nonmetallic Welding Materials (AREA)
• Control Of Positive-Displacement Air Blowers (AREA)
• Control And Other Processes For Unpacking Of Materials (AREA)
• Crystals, And After-Treatments Of Crystals (AREA)
• Stereophonic System (AREA)
• Superconductors And Manufacturing Methods Therefor (AREA)
• Paper (AREA)

Priority Applications (12)

Applications Claiming Priority (2)

Related Child Applications (1)

Publications (2)

Family

ID=7926702

Family Applications (1)

Country Status (13)

Cited By (3)

Families Citing this family (6)

Family Cites Families (10)

• 1999
  • 1999-10-15 DE DE19951189A patent/DE19951189C2/de not_active Expired - Fee Related
• 2000
  • 2000-10-13 IL IL14906700A patent/IL149067A0/xx unknown
  • 2000-10-13 ES ES00987010T patent/ES2246257T3/es not_active Expired - Lifetime
  • 2000-10-13 US US10/110,610 patent/US7179594B1/en not_active Expired - Fee Related
  • 2000-10-13 EP EP00987010A patent/EP1228246B1/de not_active Expired - Lifetime
  • 2000-10-13 DK DK00987010T patent/DK1228246T3/da active
  • 2000-10-13 JP JP2001529448A patent/JP4528475B2/ja not_active Expired - Fee Related
  • 2000-10-13 DE DE50010776T patent/DE50010776D1/de not_active Expired - Lifetime
  • 2000-10-13 CA CA002387148A patent/CA2387148A1/en not_active Abandoned
  • 2000-10-13 WO PCT/DE2000/003726 patent/WO2001027317A2/de not_active Ceased
  • 2000-10-13 NZ NZ518318A patent/NZ518318A/en not_active IP Right Cessation
  • 2000-10-13 AU AU23451/01A patent/AU775085B2/en not_active Ceased
  • 2000-10-13 AT AT00987010T patent/ATE299950T1/de active
• 2002
  • 2002-03-27 IS IS6328A patent/IS6328A/is unknown
• 2007
  • 2007-02-20 US US11/708,944 patent/US20070161036A1/en not_active Abandoned

Also Published As

Similar Documents

Legal Events